» Articles » PMID: 16445376

Surgical Options and Outcomes in Bone Sarcoma

Overview
Specialties Oncology
Pharmacology
Date 2006 Feb 1
PMID 16445376
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Bone sarcomas are challenging to treat. The primary goal of treatment is local control of the disease while, if possible, achieving salvage of the limb and its function. There is no ideal method of reconstruction in limb-salvage surgery but the choice of the method of reconstruction should be individualized based upon many factors including the patient's age, the extent and location of the tumor, the wishes of the patient, and the availability of surgical facilities and expertise, as well as the cost of the procedure. In this review, the authors explore the advantages and disadvantages of the different methods of limb reconstruction. The surgical management of bone sarcomas is a real challenge to the orthopedic surgeon, owing to the diversity of sites in which tumors arise, combined with the extension of the tumor into adjacent soft tissues and their proximity, in many cases, to major neurovascular structures. There have been dramatic improvements in survival for patients with osteosarcoma and Ewing's sarcoma in the past 30 years owing to increasing effectiveness of chemotherapy. This, along with developments in imaging techniques (magnetic resonance imaging in particular) has led to earlier diagnosis and more accurate preoperative staging. Whilst traditional treatment for bone tumors used to be amputation, advances in surgical techniques have made limb-salvage procedures a valid alternative method of treatment to amputation in 80-85% of patients with primary bone sarcomas.

Citing Articles

Shared decision making in primary malignant bone tumour surgery around the knee in children and young adults: protocol for a prospective study.

Blom K, Bekkering W, Fiocco M, van de Sande M, Schreuder H, Van der Heijden L J Orthop Surg Res. 2024; 19(1):714.

PMID: 39487545 PMC: 11531153. DOI: 10.1186/s13018-024-05192-y.


Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance.

Qin S, Wang Y, Ma C, Lv Q Eur J Med Res. 2023; 28(1):354.

PMID: 37717007 PMC: 10504747. DOI: 10.1186/s40001-023-01309-x.


A comparison of the microbiology profile for periprosthetic joint infection of knee arthroplasty and lower-limb endoprostheses in tumour surgery.

McCulloch R, Adlan A, Jenkins N, Parry M, Stevenson J, Jeys L J Bone Jt Infect. 2022; 7(4):177-182.

PMID: 36032799 PMC: 9399934. DOI: 10.5194/jbji-7-177-2022.


Evaluating a Panel of Autoantibodies Against Tumor-Associated Antigens in Human Osteosarcoma.

Luo M, Wu S, Ma Y, Liang H, Luo Y, Gu W Front Genet. 2022; 13:872253.

PMID: 35547257 PMC: 9081566. DOI: 10.3389/fgene.2022.872253.


Histotripsy Ablation of Bone Tumors: Feasibility Study in Excised Canine Osteosarcoma Tumors.

Arnold L, Hendricks-Wenger A, Coutermarsh-Ott S, Gannon J, Hay A, Dervisis N Ultrasound Med Biol. 2021; 47(12):3435-3446.

PMID: 34462159 PMC: 8578360. DOI: 10.1016/j.ultrasmedbio.2021.08.004.